Bill > HB3613

This bill establishes the Office of Pharmaceutical Purchasing (OPP) within the Oregon Department of Administrative Services to improve the state's pharmaceutical purchasing strategies. The OPP's primary goals are to support multiagency and multistate collaborative drug purchasing, reduce prescription drug costs for Oregon residents, and enhance coordination across state agencies. The bill transfers the Oregon Prescription Drug Program from the Oregon Health Authority to the new office and creates an advisory board to help coordinate pharmaceutical purchasing efforts. Key provisions include requiring certain state agencies and coordinated care organizations to participate in the program, developing a uniform Practitioner-Managed Prescription Drug Plan for fee-for-service and coordinated care organizations, and mandating annual reporting on pharmaceutical expenditures, purchasing practices, and recommendations for cost reduction. The bill also makes various technical amendments to existing laws to support the new office's functions and clarifies the roles and responsibilities of different state entities in pharmaceutical purchasing. The new office and its associated changes will become operational on January 1, 2026, with the bill taking effect 91 days after the legislative session adjourns.

Health and Social Services

https://olis.oregonlegislature.gov/liz/2025R1/Measures/Overview/HB3613